-
1
-
-
84865323065
-
Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing
-
E.S. Snitkin et al., "Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing," Sci Transl Med, 4:148ra116, 2012.
-
(2012)
Sci Transl Med
, vol.4
, pp. 148ra116
-
-
Snitkin, E.S.1
-
3
-
-
0000077049
-
Sur un microbe invisible antagoniste des bacilles dysentérique
-
F. d'Hérelle, "Sur un microbe invisible antagoniste des bacilles dysentérique," CR Acad Sci Paris, 165:373-75, 1917.
-
(1917)
CR Acad Sci Paris
, vol.165
, pp. 373-375
-
-
D'Hérelle, F.1
-
4
-
-
33947197531
-
Le bactériophage
-
F. d'Herelle, "Le bactériophage," Atomes, 3:399-403, 1948.
-
(1948)
Atomes
, vol.3
, pp. 399-403
-
-
D'Herelle, F.1
-
5
-
-
84958271199
-
-
(Translated in Sci News, 14:44-59, 1949.)
-
(1949)
Sci News
, vol.14
, pp. 44-59
-
-
-
6
-
-
0017035426
-
Who discovered bacteriophage?
-
D.H. Duckworth, "Who discovered bacteriophage?" Bacteriol Rev, 40:793-802, 1976.
-
(1976)
Bacteriol Rev
, vol.40
, pp. 793-802
-
-
Duckworth, D.H.1
-
7
-
-
84893358061
-
The first phage electron micrographs
-
H.-W. Ackermann, "The first phage electron micrographs," Bacteriophage, 1:225-27, 2011.
-
(2011)
Bacteriophage
, vol.1
, pp. 225-227
-
-
Ackermann, H.-W.1
-
8
-
-
80052695183
-
Phage treatment of human infections
-
S.T. Abedon et al., "Phage treatment of human infections," Bacteriophage, 1:66-85, 2011.
-
(2011)
Bacteriophage
, vol.1
, pp. 66-85
-
-
Abedon, S.T.1
-
9
-
-
0000675873
-
Bacteriophage therapy
-
1847-53, 1934-39
-
M.D. Eaton, S. Bayne-Jones, "Bacteriophage therapy," JAMA, 103:1769-76, 1847-53, 1934-39, 1934.
-
(1934)
JAMA
, vol.103
, pp. 1769-1776
-
-
Eaton, M.D.1
Bayne-Jones, S.2
-
10
-
-
84946594594
-
Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters
-
J.J. Barr et al., "Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters," PNAS, 112:13675-80, 2015.
-
(2015)
PNAS
, vol.112
, pp. 13675-13680
-
-
Barr, J.J.1
-
11
-
-
84862897331
-
Clinical aspects of phage therapy
-
R. Mi?dzybrodzki et al., "Clinical aspects of phage therapy," Adv Virus Res, 83:73-121, 2012.
-
(2012)
Adv Virus Res
, vol.83
, pp. 73-121
-
-
Midzybrodzki, R.1
-
12
-
-
70349906484
-
A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses
-
R. Mi?dzybrodzki et al., "A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses," Clin Exp Med, 9:303-12, 2009.
-
(2009)
Clin Exp Med
, vol.9
, pp. 303-312
-
-
Midzybrodzki, R.1
-
13
-
-
84903740818
-
Phage neutralization by sera of patients receiving phage therapy
-
M. Musiak-Szelachowska et al., "Phage neutralization by sera of patients receiving phage therapy,"Viral Immunol, 27:295-304, 2014.
-
(2014)
Viral Immunol
, vol.27
, pp. 295-304
-
-
Musiak-Szelachowska, M.1
-
14
-
-
70349775117
-
Bacteriophage therapy of venous leg ulcers in humans: Results of a Phase i safety trial
-
240-43
-
D.D. Rhoads et al., "Bacteriophage therapy of venous leg ulcers in humans: Results of a Phase I safety trial," J Wound Care, 18:237-38, 240-43, 2009.
-
(2009)
J Wound Care
, vol.18
, pp. 237-238
-
-
Rhoads, D.D.1
|